Member access

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
01/13Presentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Financials ( CHF)
Sales 2014 47 320 M
EBIT 2014 17 593 M
Net income 2014 11 740 M
Debt 2014 6 657 M
Yield 2014 3,04%
Sales 2015 49 738 M
EBIT 2015 18 883 M
Net income 2015 12 805 M
Debt 2015 837 M
Yield 2015 3,29%
PER 2014 19,49
PER 2015 17,62
EV / Sales 2014 5,07x
EV / Sales 2015 4,71x
Capitalization 233 373 M
More Financials
Latest news on ROCHE HOLDING LTD.
3d ago ROCHE : says agrees to buy Bina Technologies for undisclosed price
3d agoDJROCHE : Stops Alzheimer Drug Trial; Shows Mixed Results in Breast Cancer Study
3d ago ROCHE : Genentech : Provides Update on Phase III MARIANNE Study in People with P..
4d ago Roche to pay up to $489 million for next-generation antibody developer
5d agoDJFrance Told To Do More for Foreign Investors
12/15 ROCHE : Genentech : Submits New Drug Application to FDA for Investigational Cobi..
12/12DJNOVARTIS : Afinitor Fails to Make a Significant Treatment Difference
12/12DJROCHE : Correction to Roche story
More news
Sector news
4m ago Lilly must divest Sentinel products after FTC nod on Novartis deal
21m ago Shares higher on year-end buying, European energy boost
23m ago GLAXOSMITHKLINE : GSK announces US regulatory submission seeking additional indi..
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF